Dogwood Therapeutics DWTX
NASDAQ DWTX
$1.18 -0.05 (-4.07%)
At close: Nov 11, 2026 · 4:00 PM EST

Dogwood Therapeutics (DWTX) Operating Leases (2024 - 2026)

Updated

Dogwood Therapeutics (DWTX) posted Operating Leases of $69,563 for Q2 2026, down 47.5% from $132,494 a year earlier and down 20.6% from the prior quarter.

Analysis

Dogwood Therapeutics (DWTX) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Dogwood Therapeutics' Operating Leases came in at $105,763, down 31.7% from FY2024.

  • In prior years, Dogwood Therapeutics' Operating Leases was $154,885 in FY2024.
  • On a year-over-year basis, Operating Leases has declined in each of the last three quarters.
  • According to Business Quant data, Operating Leases for the three prior quarters was $87,616 (Q1 2026), $105,763 (Q4 2025) and $120,212 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Dogwood Therapeutics 41.98 Mn 7.67 Mn 11,896.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 58,868.00
Jun 30, 2026 69,563.00
Mar 31, 2026 87,616.00
Dec 31, 2025 105,763.00
Sep 30, 2025 120,212.00
Jun 30, 2025 132,494.00
Mar 31, 2025 140,525.00
Dec 31, 2024 154,885.00
API Access

Dogwood Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=DWTX&period=max&api_key=YOUR_API_KEY